PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK.\', \'Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore della Carità Hospital, Novara, Italy.\', \'Department of Medical Oncology, University of Ioannina, Ioannina, Greece; Chief Medical Officer, European Society for Medical Oncology, Lugano, Switzerland.\', \'Department of Medical Oncology, Center for Cancer Immunotherapy, Institut Curie, Paris, France.\', \'Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK; Department of Biotechnology and Applied Clinical Sciences, University of L\'Aquila, L\'Aquila, Italy. Electronic address: a.cortellini@imperial.ac.uk.\', \'Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore della Carità Hospital, Novara, Italy. Electronic address: david.pinato@imperial.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2059-7029(21)00082-X10.1016/j.esmoop.2021.100123
?:doi
?:hasPublicationType
?:journal
  • ESMO open
is ?:pmid of
?:pmid
?:pmid
  • 33932622
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancer.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all